The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Open accessAbstract
BACKGROUND: Recognizing the rapidly increasing interest and evidence in using metastasis-directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO convened a committee to establish consensus regarding definitions of OMD and define gaps in current evidence. METHODS: A systematic literature review focused on curative intent MDRT was performed in Medline, Embase and Cochrane. Subsequent consensus opinion, using a Delphi process, highlighted the current state of evidence and the limitations in the available literature. RESULTS: Available evidence regarding the use of MDRT for OMD mostly derives from retrospective, single-centre series, with significant heterogeneity in patient inclusion criteria, definition of OMD, and outcomes reported. Consensus was reached that OMD is largely independent of primary tumour, metastatic location and the presence or length of a disease-free interval, supporting both synchronous and metachronous OMD. In the absence of clinical data supporting a maximum number of metastases and organs to define OMD, and of validated molecular biomarkers, consensus supported the ability to deliver safe and clinically meaningful radiotherapy with curative intent to all metastatic sites as a minimum requirement for defining OMD in the context of radiotherapy. Systemic therapy induced OMD was identified as a distinct state of OMD. High-resolution imaging to assess and confirm OMD is crucial, including brain imaging when indicated. Minimum common endpoints such as progression-free and overall survival, local control, toxicity and quality-of-life should be reported; uncommon endpoints as deferral of systemic therapy and cost were endorsed. CONCLUSION: While significant heterogeneity exists in the current OMD definitions in the literature, consensus was reached on multiple key questions. Based on available data, OMD can to date be defined as 1-5 metastatic lesions, a controlled primary tumor being optional, but where all metastatic sites must be safely treatable. Consistent definitions and reporting are warranted and encouraged in ongoing trials and reports generating further evidence to optimize patient benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Fong, Y., Fortner, J., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199909000-00004 · Cited by 3,715
Hellman, S., & Weichselbaum, R. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.8 · Cited by 2,562
Palma, D. A., Olson, R., Harrow, S., Gaede, S., Louie, A. V., Haasbeek, C., Mulroy, L., Lock, M., Rodrigues, G. B., Yaremko, B. P., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32487-5 · Cited by 1,857
Self-citationOst, P., Reynders, D., Decaestecker, K., Fonteyne, V., Lumen, N., De Bruycker, A., Lambert, B., Delrue, L., Bultijnck, R., Claeys, T., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.4853 · Cited by 1,351
Gomez, D. R., Tang, C., Zhang, J., Blumenschein, G. R., Hernandez, M., Lee, J. J., Ye, R., Palma, D. A., Louie, A. V., Camidge, D. R., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00201 · Cited by 1,283
Self-citationGuckenberger, M., Lievens, Y., Bouma, A. B., Collette, L., Dekker, A., deSouza, N. M., Dingemans, A.-M. C., Fournier, B., Hurkmans, C., Lecouvet, F. E., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30718-1 · Cited by 1,111
Self-citationGomez, D. R., Blumenschein, G. R., Lee, J. J., Hernandez, M., Ye, R., Camidge, D. R., Doebele, R. C., Skoulidis, F., Gaspar, L. E., Gibbons, D. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30532-0 · Cited by 1,086
Self-citationIyengar, P., Wardak, Z., Gerber, D. E., Tumati, V., Ahn, C., Hughes, R. S., Dowell, J. E., Cheedella, N., Nedzi, L., Westover, K. D., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3501 · Cited by 1,047
Self-citationLocal Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Ruers, T., Van Coevorden, F., Punt, C. J. A., Pierie, J.-P. E. N., Borel-Rinkes, I., Ledermann, J. A., Poston, G., Bechstein, W., Lentz, M.-A., Mauer, M., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx015 · Cited by 682
Stereotactic body radiotherapy for oligometastases
Tree, A. C., Khoo, V. S., Eeles, R. A., Ahmed, M., Dearnaley, D. P., Hawkins, M. A., Huddart, R. A., Nutting, C. M., Ostler, P. J., & van As, N. J. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70510-7 · Cited by 524
Milano, M. T., Katz, A. W., Zhang, H., & Okunieff, P. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.08.036 · Cited by 439
Phase II study on stereotactic body radiotherapy of colorectal metastases
Hoyer, M., Roed, H., Traberg Hansen, A., Ohlhuis, L., Petersen, J., Nellemann, H., Kiil Berthelsen, A., Grau, C., Aage Engelholm, S., & Von Der Maase, H. (2006) · Acta Oncologica · doi:10.1080/02841860600904854 · Cited by 426
Self-citationOligometastases and Oligo-recurrence: The New Era of Cancer Therapy
Niibe, Y., & Hayakawa, K. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp167 · Cited by 359
Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma
Hoyer, M., Roed, H., Sengelov, L., Traberg, A., Ohlhuis, L., Pedersen, J., Nellemann, H., Kiil Berthelsen, A., Eberholst, F., Engelholm, S. A., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.12.022 · Cited by 353
Self-citationThe biology and treatment of oligometastatic cancer
Reyes, D. K., & Pienta, K. J. (2015) · Oncotarget · doi:10.18632/oncotarget.3455 · Cited by 320
Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
Dingemans, A.-M. C., Hendriks, L. E. L., Berghmans, T., Levy, A., Hasan, B., Faivre-Finn, C., Giaj-Levra, M., Giaj-Levra, N., Girard, N., Greillier, L., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.07.025 · Cited by 294
Self-citationOst, P., Jereczek-Fossa, B. A., As, N. V., Zilli, T., Muacevic, A., Olivier, K., Henderson, D., Casamassima, F., Orecchia, R., Surgo, A., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.07.004 · Cited by 290
MicroRNA Expression Characterizes Oligometastasis(es)
Lussier, Y. A., Xing, H. R., Salama, J. K., Khodarev, N. N., Huang, Y., Zhang, Q., Khan, S. A., Yang, X., Hasselle, M. D., Darga, T. E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028650 · Cited by 281
The oligometastatic state—separating truth from wishful thinking
Palma, D. A., Salama, J. K., Lo, S. S., Senan, S., Treasure, T., Govindan, R., & Weichselbaum, R. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.96 · Cited by 277
Self-citationRepeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Decaestecker, K., De Meerleer, G., Lambert, B., Delrue, L., Fonteyne, V., Claeys, T., De Vos, F., Huysse, W., Hautekiet, A., Maes, G., et al. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-135 · Cited by 255
Pitroda, S. P., Khodarev, N. N., Huang, L., Uppal, A., Wightman, S. C., Ganai, S., Joseph, N., Pitt, J., Brown, M., Forde, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04278-6 · Cited by 254
Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases
Miller, G., Biernacki, P., Kemeny, N. E., Gonen, M., Downey, R., Jarnagin, W. R., D’Angelica, M., Fong, Y., Blumgart, L. H., & DeMatteo, R. P. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.04.039 · Cited by 203
Lussier, Y. A., Khodarev, N. N., Regan, K., Corbin, K., Li, H., Ganai, S., Khan, S. A., Gnerlich, J., Darga, T. E., Fan, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050141 · Cited by 201
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial
Trovo, M., Furlan, C., Polesel, J., Fiorica, F., Arcangeli, S., Giaj-Levra, N., Alongi, F., Del Conte, A., Militello, L., Muraro, E., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.08.032 · Cited by 165
Andratschke, N. H., Alheid, H., Allgäuer, M., Becker, G., Blanck, O., Boda‐Heggemann, J., Brunner, T. B., Duma, M. N., Gerum, S., Gückenberger, M., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4191-2 · Cited by 157
Schick, U., Jorcano, S., Nouet, P., Rouzaud, M., Vees, H., Zilli, T., Ratib, O. M., Weber, D. C., & Miralbell, R. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.764010 · Cited by 156
Rieber, J., Streblow, J., Uhlmann, L., Flentje, M. P., Duma, M. N., Ernst, I., Blanck, O., Wittig, A., Boda‐Heggemann, J., Krempien, R. C., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.04.012 · Cited by 153
Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases
Lewis, S. L., Porceddu, S. V., Nakamura, N., Palma, D. A., Lo, S. S.-M., Hoskin, P., Moghanaki, D. M., Chmura, S. J., & Salama, J. K. (2015) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000169 · Cited by 151
Self-citationTriggiani, L., Alongi, F., Buglione, M., Detti, B., Santoni, R., Bruni, A., Maranzano, E., Lohr, F., D’Angelillo, R. M., Magli, A., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.103 · Cited by 151
Bleser, E. D., Jereczek‐Fossa, B. A., Pasquier, D., Zilli, T., van As, N. J., Siva, S., Fodor, A., Dirix, P. R., Iturriaga, A. G., Trippa, F., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.07.009 · Cited by 142
deSouza, N. M., Liu, Y., Chiti, A., Oprea‐Lager, D. E., Gebhart, G., BEERS, B. E. V., Herrmann, K., & Lecouvet, F. E. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2017.12.012 · Cited by 140
Wong, A., Watson, S. P., Pitroda, S. P., Son, C. H., Das, L. C., Stack, M. E., Uppal, A., Oshima, G., Khodarev, N. N., Salama, J. K., et al. (2016) · Cancer · doi:10.1002/cncr.30058 · Cited by 138
Fode, M. M., & Høyer, M. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.12.003 · Cited by 119
Greco, C., Zeléfsky, M. J., Lovelock, M., FUKS, Z. Y., Hunt, M. A., Rosenzweig, K. E., Zatcky, J., Kim, B., & Yamada, Y. J. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.038 · Cited by 113
Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
de Vin, T., Engels, B., Gevaert, T., Storme, G. A., & Ridder, M. D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt537 · Cited by 102
Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday
Lazzari, R., Ronchi, S., Gandini, S., Surgo, A., Volpe, S., Piperno, G., Comi, S., Pansini, F., Fodor, C. I., Orecchia, R., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.03.058 · Cited by 98
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Navarria, P., Ascolese, A. M., Tomatis, S., Cozzi, L., Rose, F. D., Mancosu, P., Alongi, F., Clerici, E., Lobefalo, F., Tozzi, A., et al. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-91 · Cited by 94
Self-citationFleckenstein, J., Petroff, A., Schäfers, H., Wehler, T., Schöpe, J., & Rübe, C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2379-x · Cited by 90
Sutera, P. A., Clump, D. A., Kalash, R., D'Ambrosio, D. J., Mihai, A., Wang, H., Petro, D. P., Burton, S. A., & Heron, D. E. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.08.027 · Cited by 85
Oligometastases confined one organ from colorectal cancer treated by SBRT
Kang, J.-K., Kim, M., Kim, J. H., Yoo, S. Y., Cho, C. K., Yang, K., Yoo, H. J., Seo, Y. S., Lee, D. H., Kang, H. J., et al. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9325-0 · Cited by 83
Meyer, E., Pasquier, D., Bernadou, G., Calais, G., Maroun, P., Bossi, A., Théodore, C., Albiges, L. K., Stefan, D., de Crevoisier, R., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.04.008 · Cited by 82
Binkley, M. S., Trakul, N., Jacobs, L. R., von Eyben, R., Le, Q., Maxim, P. G., Loo, B. W., Shultz, D. B., & Diehn, M. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.04.004 · Cited by 81
Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review
Giaj‐Levra, N., Levra, M. G., Durieux, V., Novello, S., Besse, B., Hasan, B., Hendriks, L. E. L., Lévy, A., Dingemans, A. C., & Berghmans, T. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.05.037 · Cited by 74
Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases
Goodman, B. D., Mannina, E. M., Althouse, S. K., Maluccio, M. A., & Cardenes, H. R. (2015) · Practical Radiation Oncology · doi:10.1016/j.prro.2015.10.011 · Cited by 72
Bowden, P., See, A. W., Frydenberg, M., Haxhimolla, H. Z., Costello, A. J., MOON, D. A., Ruljancich, P., Grummet, J., Crosthwaite, A., Pranavan, G., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32509 · Cited by 71
Helou, J., Thibault, I., Poon, I., Chiang, A., Jain, S., Soliman, H., Erler, D., Yeung, L., & Cheung, P. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.02.093 · Cited by 69
Petty, W. J., Urbanic, J. J., Ahmed, T., Hughes, R. T., Levine, B. J., Rusthoven, K. E., Papagikos, M. A., Ruiz, J., Lally, B. E., Chan, M. D., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.06.400 · Cited by 66
Erler, D., Brotherston, D., Sahgal, A., Cheung, P., Loblaw, A., Chu, W., Soliman, H., Chung, H. T.-K., Kiss, A., Chow, E., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.03.030 · Cited by 65
Al-Shafa, F., Arifin, A. J., Rodrigues, G., Palma, D. A., & Louie, A. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00543 · Cited by 65
Self-citationSchanne, D. H., Schaule, J., Gückenberger, M., & Andratschke, N. H. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101892 · Cited by 63
Lievens, Y. N., Audisio, R. A., Banks, I., Collette, L., Grau, C., Oliver, K. R., Price, R., & Aggarwal, A. K. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30917-3 · Cited by 60
Self-citationOh, D., Ahn, Y. C., Seo, J. M., Shin, E., Park, H. C., Lim, D. H., & Pyo, H. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.681698 · Cited by 59
Hu, F., Xu, J., Zhang, B., Li, C., Nie, W., Gu, P., Hu, P., Wang, H., Zhang, Y., Shen, Y., et al. (2018) · Clinical Lung Cancer · doi:10.1016/j.cllc.2018.09.010 · Cited by 59
Rose, F. D., Cozzi, L., Navarria, P., Ascolese, A. M., Clerici, E., Infante, M. V., Alloisio, M., Testori, A., Toschi, L., Finocchiaro, G., et al. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.08.011 · Cited by 54
Self-citationClinical Outcomes of Single Dose Stereotactic Radiotherapy for Lung Metastases
Osti, M. F., Carnevale, A., Valeriani, M., Sanctis, V. D., Minniti, G. C., Cortesi, E., Martelli, M., & Enrici, R. M. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.06.006 · Cited by 51
Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study
Aoki, M., Hatayama, Y., Kawaguchi, H., Hirose, K., Sato, M., Akimoto, H., Miura, H., Ono, S., & Takai, Y. (2015) · Journal of Radiation Research · doi:10.1093/jrr/rrv063 · Cited by 49
Merino, T., Helou, J. A., Poon, I., Sahgal, A., Chung, H. T.-K., Chu, W., Soliman, H., Ung, Y., Verma, S., Cheema, P. K., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.08.005 · Cited by 49
Laurie, S. A., Banerji, S. O., Blais, N., Brule, S. Y., Cheema, P. K., Cheung, P., Daaboul, N., Hao, D., Hirsh, V., Juergens, R. A., et al. (2019) · Current Oncology · doi:10.3747/co.26.4116 · Cited by 48
Hörner‐Rieber, J., Bernhardt, D., Blanck, O., Duma, M. N., Eich, H. T., Gerum, S., Gkika, E., Hass, P., Henkenberens, C., Herold, H., et al. (2019) · Clinical Lung Cancer · doi:10.1016/j.cllc.2019.06.024 · Cited by 48
Sharma, A., Duijm, M., Hoop, E. O., Aerts, J. G. J. V., Verhoef, C. K., Hoogeman, M. S., & Nuyttens, J. J. M. E. (2018) · Acta Oncologica · doi:10.1080/0284186x.2018.1521986 · Cited by 46
Nguyen, T. K., Senan, S., Bradley, J. D., Franks, K., Giuliani, M., Gückenberger, M., Landis, M. S., Loo, B. W., Louie, A. V., Onishi, H., et al. (2017) · Practical Radiation Oncology · doi:10.1016/j.prro.2017.10.008 · Cited by 45
Self-citationKlement, R. J., Hoerner‐Rieber, J., Adebahr, S., Andratschke, N. H., Blanck, O., Boda‐Heggemann, J., Duma, M. N., Eble, M. J., Eich, H. C., Flentje, M. P., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.02.016 · Cited by 45
Franceschini, D., Rose, F. D., Franzese, C., Comito, T., Brina, L. D., Radicioni, G., Evangelista, A., D’Agostino, G. R., Navarria, P., & Scorsetti, M. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.12.049 · Cited by 45
Self-citationOsti, M. F., Agolli, L., Valeriani, M., Reverberi, C., Bracci, S., Marinelli, L., Sanctis, V. D., Cortesi, E., Martelli, M. P., Dominicis, C. D., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.06.018 · Cited by 44
Kinj, R., Bondiau, P., François, É., Gérard, J., Naghavi, A. O., Leysalle, A., Chamorey, E., Evesque, L., Padovani, B., Ianessi, A., et al. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.08.003 · Cited by 40
Kwint, M., Walraven, I., Burgers, S. J. A., Hartemink, K. J., Klomp, H. M., Knegjens, J., Verheij, M., & Belderbos, J. S. A. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.08.006 · Cited by 40
Pembroke, C., Fortin, B., & Kopek, N. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.04.022 · Cited by 39
Yamashita, H., Niibe, Y., Yamamoto, T., Katsui, K., Jingu, K., Kanazawa, S., Terahara, A., & Nakagawa, K. (2016) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyw047 · Cited by 38
Santini, D., Ratta, R., Pantano, F., Lisi, D. D., Maruzzo, M., Galli, L., Biasco, E., Farnesi, A., Buti, S., Sternberg, C. N., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20022 · Cited by 38
Mazzola, R., Fersino, S., Ferrera, G., Targher, G., Figlia, V., Triggiani, L., Pasinetti, N., Casto, A. L., Ruggieri, R., Magrini, S. M., et al. (2018) · Medical Oncology · doi:10.1007/s12032-018-1190-8 · Cited by 38
Locoregional control and survival after lymph node SBRT in oligometastatic disease
Loi, M., Frelinghuysen, M., Klass, N. D., Hoop, E. O., Granton, P. V., Aerts, J. G. J. V., Verhoef, C. K., & Nuyttens, J. J. M. E. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9922-x · Cited by 37
Dhondt, B., Bleser, E. D., Claeys, T., Buelens, S., Lumen, N., Vandesompele, J., Beckers, A., Fonteyne, V., der Eecken, K. V., Bruycker, A. D., et al. (2018) · World Journal of Urology · doi:10.1007/s00345-018-2609-8 · Cited by 36
Siva, S., Kirby, K., Caine, H., Pham, D., Kron, T., Marvelde, L. T., Whalley, D., Stevens, M. J., Foroudi, F., MacManus, M. P., et al. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.01.004 · Cited by 35
Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours
Franceschini, D., Cozzi, L., Rose, F. D., Navarria, P., Franzese, C., Comito, T., Iftode, C., Tozzi, A., Brina, L. D., Ascolese, A. M., et al. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2373-y · Cited by 35
Self-citationFranzese, C., Zucali, P. A., Brina, L. D., D’Agostino, G. R., Navarria, P., Franceschini, D., Santoro, A., & Scorsetti, M. (2018) · Cancer Medicine · doi:10.1002/cam4.1707 · Cited by 34
Self-citationden Begin, R. V., Engels, B., Collen, C., de Vin, T., Defauw, A., Dubaere, E., Barbé, K., & Ridder, M. D. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.01.001 · Cited by 34
Access to innovative radiotherapy: how to make it happen from an economic perspective?
Lievens, Y. N. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1348622 · Cited by 31
Self-citationStereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease
Bhattacharya, I. S., Woolf, D. K., Hughes, R. J., Shah, N., Harrison, M., Ostler, P. J., & Hoskin, P. (2015) · British Journal of Radiology · doi:10.1259/bjr.20140712 · Cited by 29
Ouyang, W., Yu, J., Shuake, N., Li, Z., Wang, D., Wang, X., Zhang, J., & Xie, C. (2019) · Cancer Medicine · doi:10.1002/cam4.2366 · Cited by 26
Self-citationBarata, P. C., Mendiratta, P., Kotecha, R. R., Gopalakrishnan, D., Juloori, A., Chao, S. T., Koshkin, V. S., Ornstein, M. C., Gilligan, T. D., Wood, L. S., et al. (2018) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2018.07.018 · Cited by 24
Franzese, C., Cozzi, L., Franceschini, D., D’Agostino, G. R., Comito, T., Rose, F. D., Navarria, P., Mancosu, P., Tomatis, S., Fogliata, A., et al. (2016) · Cancer Investigation · doi:10.1080/07357907.2016.1197235 · Cited by 20
Self-citationLancia, A., Ingrosso, G., Carosi, A., Murro, L. D., Giudice, E., Cicchetti, S., Morelli, P., di Cristino, D., Bruni, C., Murgia, A., et al. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1346383 · Cited by 20
Napieralska, A., Miszczyk, L., & Stąpór-Fudzińska, M. (2016) · Neoplasma · doi:10.4149/218_150807n435 · Cited by 19
Deodato, F., Macchia, G., Cilla, S., Ianiro, A., Sallustio, G., Cammelli, S., Buwenge, M., Mattiucci, G. C., Valentini, V., & MORGANTI, A. G. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180422 · Cited by 17
Aujla, K. S., Katz, A. W., Singh, D. P., Okunieff, P. G., & Milano, M. T. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00111 · Cited by 12
Cited by
Management of Salivary Gland Malignancy: ASCO Guideline
Geiger, J. L., Ismaila, N., Beadle, B., Caudell, J. J., Chau, N., Deschler, D., Glastonbury, C., Kaufman, M., Lamarre, E., Lau, H. Y., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00449 · Cited by 441
Contemporary radiotherapy: present and future
Chandra, R. A., Keane, F. K., Voncken, F. E. M., & Thomas, C. R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00233-6 · Cited by 380
Tsai, C. J., Yang, J. T., Shaverdian, N., Patel, J., Shepherd, A. F., Eng, J., Guttmann, D., Yeh, R., Gelblum, D. Y., Namakydoust, A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01857-3 · Cited by 283
Self-citationOligometastatic Colorectal Cancer: A Review of Definitions and Patient Selection for Local Therapies
Miller, E. D., Hitchcock, K. E., & Romesser, P. B. (2023) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-022-00900-5 · Cited by 31
Minimally invasive interventional procedures for metastatic bone disease: A comprehensive review
Papalexis, N., Parmeggiani, A., Peta, G., Spinnato, P., Miceli, M., & Facchini, G. (2022) · Current Oncology · doi:10.3390/curroncol29060332 · Cited by 29
Metadata
- Authors
- Lievens, Y., Guckenberger, M., Gomez, D., Hoyer, M., Iyengar, P., Kindts, I., Méndez Romero, A., Nevens, D., Palma, D., Park, C., Ricardi, U., Scorsetti, M., Yu, J., & Woodward, W. A.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 148
- Pages
- 157-166
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W3019546741
- Cited by
- 672
- References
- 87
- FWCI
- 71.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.